Allergan stops sales in Europe of breast implants linked to cancer
Share:
PARIS (Reuters) - Breast implants made by drugmaker Allergan , which have been linked to a rare form of cancer, are being taken off the market in Europe, said a French regulatory body.France's National Agency for the Safety of Medicines & Health Products (ANSM) said in a statement late Tuesday that the decision concerned Allergan's Microcell and Biocell products.The French regulator added that it had not identified any immediate risk for the health of women carrying these implants.Allergan, best..